Levofloxacin and glycaemic disorders. Diabetic patients: beware.
D002170:Canada; D003920:Diabetes Mellitus / Q000139:chemically induced* / Q000188:drug therapy; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced*; D007003:Hypoglycemia / Q000139:chemically induced*; D064704:Levofloxacin; D015242:Ofloxacin / Q000009:adverse effects* / Q000627:therapeutic use
D064704:Levofloxacin; D015242:Ofloxacin